SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (22)10/31/2000 2:32:48 PM
From: scaram(o)uche  Respond to of 1784
 
MS... that's why I'm in MDZ. Modestly.

Protana.



To: tuck who wrote (22)10/31/2000 6:52:19 PM
From: JEB  Read Replies (1) | Respond to of 1784
 
Enzo Biochem is a manufacturer of diagnostic dna probe technology:

enzo.com

Also, they have a division that has two clinical (true genomic) therapy trials for hepatitis B and AIDS.

;-)
JEB



To: tuck who wrote (22)10/31/2000 7:34:15 PM
From: hm  Respond to of 1784
 
>>Off to check MS makers out. Help appreciated<<

Waters has a big MS division courtesy of buying Micromass a few years back. IMO, Waters could be a core holding of this 'folio. And it's multiple, while high, is a bit more palatable than PEB for a similar growth rate.

waters.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News